Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Paediatric Patients

Registry ID

EUCTR2017-003841-39

Source registry

EUCTR

Phase

PHASE4

Sponsor

Alcon Research

Last update

2026-08-16

Conditions

• allergic conjunctivitis

Summary

The purpose of this study is to evaluate the safety of Olopatadine Ophthalmic Solution 0.1% in Japanese children with allergic conjunctivitis.

View on source registry